We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Support for commissioners and providers of mental healthcare to shift to new payment approaches.
How to use a behaviour change techniques review to evaluate your digital health product.
The home of Companies House on GOV.UK. We incorporate and dissolve limited companies. We register company information and make it available to the public.
The minutes of the ministerial annual accountability review of the National Institute for Health and Care Excellence (NICE).
Guidance and forms for applying for a premises licence to sell alcohol, late night hot food and drink or provide public entertainment.
Guidance primarily aimed at local responders covering some humanitarian issues that may arise during the recovery phase of an emergency in the UK.
Toolkit to help with the implementation of NICE guidelines for improving the oral health of adults in care homes.
Healthcare professionals prescribing nitrofurantoin should be alert to the risks of pulmonary and hepatic adverse drug reactions and advise patients to be vigilant for the signs and symptoms in need of further investigation.
As part of his review on pro-innovation regulation for the life sciences, Sir Patrick Vallance has written to the Chancellor with interim recommendations.
Risk of tuberculosis - screen all patients before starting treatment and monitor them closely.
Overview of organisations supporting life sciences in the UK, organised by sub-sector and stage of product or service development.
Information on antimicrobial resistance (AMR), effective methods to avoid unnecessary prescribing of antibiotics and advice for healthcare professionals.
A professional resource on improving the detection and treatment of the high-risk conditions atrial fibrillation, high blood pressure and high cholesterol
Overview of the UK's cardiovascular disease research infrastructure and advantage of investment in the UK's life science sector to support new treatments.
Key MHRA advice and guidance issued so far on medicines safety and pharmacovigilance, including on reporting to the Yellow Card Scheme.
Quick reference tools for primary care providers for diagnosing and understanding culture results for urinary tract infections (UTIs).
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).